Statements Author contributions All authors contributed to the article and approved the submitted version
Patients are advised to use barrier contraception or switch to non-oral methods during the initiation phase and for 4 weeks following each dose escalation
Weight Loss Semaglutide: A New Approach to Weight Loss Semaglutide, a medication originally developed to treat type 2 diabetes, has gained significant attention for its potential to aid in weight loss
Glucagonlike peptide1: actions and influence on pancreatic hormone function
DSIP (Delta Sleep-Inducing Peptide) is a synthetic nonapeptide originally isolated from the cerebral venous blood of rabbits during slow-wave sleep induction experiments conducted by Monnier and colleagues in the 1970s
EMBREE, J.W., LYON, J.P., & HINE, C.H